Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

P3 Health Partners (PIII) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to 12.66%.

  • P3 Health Partners' EBITDA Margin rose 167200.0% to 12.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.48%, marking a year-over-year decrease of 9400.0%. This contributed to the annual value of 21.21% for FY2024, which is 81300.0% down from last year.
  • P3 Health Partners' EBITDA Margin amounted to 12.66% in Q3 2025, which was up 167200.0% from 9.42% recorded in Q2 2025.
  • P3 Health Partners' 5-year EBITDA Margin high stood at 6.21% for Q2 2023, and its period low was 338.31% during Q2 2022.
  • Its 5-year average for EBITDA Margin is 44.84%, with a median of 17.96% in 2021.
  • Its EBITDA Margin has fluctuated over the past 5 years, first crashed by -3203500bps in 2022, then soared by 3321000bps in 2023.
  • Over the past 5 years, P3 Health Partners' EBITDA Margin (Quarter) stood at 48.98% in 2021, then tumbled by -324bps to 207.56% in 2022, then skyrocketed by 91bps to 18.38% in 2023, then crashed by -102bps to 37.18% in 2024, then surged by 66bps to 12.66% in 2025.
  • Its EBITDA Margin was 12.66% in Q3 2025, compared to 9.42% in Q2 2025 and 10.04% in Q1 2025.